MDC 17 : Myeloproliferative diseases and disorders, poorly differentiated neoplasms
8,484 Procedural Codes are assigned to this MDC
00163K8 Bypass Cerebral Ventricle to Bone Marrow with Nonautologous Tissue Substitute, Percutaneous Approach
00163KB Bypass Cerebral Ventricle to Cerebral Cisterns with Nonautologous Tissue Substitute, Percutaneous Approach
0016470 Bypass Cerebral Ventricle to Nasopharynx with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016471 Bypass Cerebral Ventricle to Mastoid Sinus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016472 Bypass Cerebral Ventricle to Atrium with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016473 Bypass Cerebral Ventricle to Blood Vessel with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016474 Bypass Cerebral Ventricle to Pleural Cavity with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016475 Bypass Cerebral Ventricle to Intestine with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016476 Bypass Cerebral Ventricle to Peritoneal Cavity with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016477 Bypass Cerebral Ventricle to Urinary Tract with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016478 Bypass Cerebral Ventricle to Bone Marrow with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
001647B Bypass Cerebral Ventricle to Cerebral Cisterns with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
00164J0 Bypass Cerebral Ventricle to Nasopharynx with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J1 Bypass Cerebral Ventricle to Mastoid Sinus with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J2 Bypass Cerebral Ventricle to Atrium with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J3 Bypass Cerebral Ventricle to Blood Vessel with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J4 Bypass Cerebral Ventricle to Pleural Cavity with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J5 Bypass Cerebral Ventricle to Intestine with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J6 Bypass Cerebral Ventricle to Peritoneal Cavity with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J7 Bypass Cerebral Ventricle to Urinary Tract with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J8 Bypass Cerebral Ventricle to Bone Marrow with Synthetic Substitute, Percutaneous Endoscopic Approach
00164JB Bypass Cerebral Ventricle to Cerebral Cisterns with Synthetic Substitute, Percutaneous Endoscopic Approach
00164K0 Bypass Cerebral Ventricle to Nasopharynx with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K1 Bypass Cerebral Ventricle to Mastoid Sinus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K2 Bypass Cerebral Ventricle to Atrium with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K3 Bypass Cerebral Ventricle to Blood Vessel with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K4 Bypass Cerebral Ventricle to Pleural Cavity with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K5 Bypass Cerebral Ventricle to Intestine with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K6 Bypass Cerebral Ventricle to Peritoneal Cavity with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K7 Bypass Cerebral Ventricle to Urinary Tract with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K8 Bypass Cerebral Ventricle to Bone Marrow with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164KB Bypass Cerebral Ventricle to Cerebral Cisterns with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
001U072 Bypass Spinal Canal to Atrium with Autologous Tissue Substitute, Open Approach
001U074 Bypass Spinal Canal to Pleural Cavity with Autologous Tissue Substitute, Open Approach
001U076 Bypass Spinal Canal to Peritoneal Cavity with Autologous Tissue Substitute, Open Approach
001U077 Bypass Spinal Canal to Urinary Tract with Autologous Tissue Substitute, Open Approach
001U079 Bypass Spinal Canal to Fallopian Tube with Autologous Tissue Substitute, Open Approach
001U0J2 Bypass Spinal Canal to Atrium with Synthetic Substitute, Open Approach
001U0J4 Bypass Spinal Canal to Pleural Cavity with Synthetic Substitute, Open Approach
001U0J6 Bypass Spinal Canal to Peritoneal Cavity with Synthetic Substitute, Open Approach
001U0J7 Bypass Spinal Canal to Urinary Tract with Synthetic Substitute, Open Approach
001U0J9 Bypass Spinal Canal to Fallopian Tube with Synthetic Substitute, Open Approach
001U0K2 Bypass Spinal Canal to Atrium with Nonautologous Tissue Substitute, Open Approach
001U0K4 Bypass Spinal Canal to Pleural Cavity with Nonautologous Tissue Substitute, Open Approach
001U0K6 Bypass Spinal Canal to Peritoneal Cavity with Nonautologous Tissue Substitute, Open Approach
001U0K7 Bypass Spinal Canal to Urinary Tract with Nonautologous Tissue Substitute, Open Approach
001U0K9 Bypass Spinal Canal to Fallopian Tube with Nonautologous Tissue Substitute, Open Approach
001U372 Bypass Spinal Canal to Atrium with Autologous Tissue Substitute, Percutaneous Approach
001U374 Bypass Spinal Canal to Pleural Cavity with Autologous Tissue Substitute, Percutaneous Approach
001U376 Bypass Spinal Canal to Peritoneal Cavity with Autologous Tissue Substitute, Percutaneous Approach
001U377 Bypass Spinal Canal to Urinary Tract with Autologous Tissue Substitute, Percutaneous Approach
001U379 Bypass Spinal Canal to Fallopian Tube with Autologous Tissue Substitute, Percutaneous Approach
001U3J2 Bypass Spinal Canal to Atrium with Synthetic Substitute, Percutaneous Approach
001U3J4 Bypass Spinal Canal to Pleural Cavity with Synthetic Substitute, Percutaneous Approach
001U3J6 Bypass Spinal Canal to Peritoneal Cavity with Synthetic Substitute, Percutaneous Approach
001U3J7 Bypass Spinal Canal to Urinary Tract with Synthetic Substitute, Percutaneous Approach
001U3J9 Bypass Spinal Canal to Fallopian Tube with Synthetic Substitute, Percutaneous Approach
001U3K2 Bypass Spinal Canal to Atrium with Nonautologous Tissue Substitute, Percutaneous Approach
001U3K4 Bypass Spinal Canal to Pleural Cavity with Nonautologous Tissue Substitute, Percutaneous Approach
001U3K6 Bypass Spinal Canal to Peritoneal Cavity with Nonautologous Tissue Substitute, Percutaneous Approach
001U3K7 Bypass Spinal Canal to Urinary Tract with Nonautologous Tissue Substitute, Percutaneous Approach
001U3K9 Bypass Spinal Canal to Fallopian Tube with Nonautologous Tissue Substitute, Percutaneous Approach
001U472 Bypass Spinal Canal to Atrium with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
001U474 Bypass Spinal Canal to Pleural Cavity with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
001U476 Bypass Spinal Canal to Peritoneal Cavity with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
001U477 Bypass Spinal Canal to Urinary Tract with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
001U479 Bypass Spinal Canal to Fallopian Tube with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
001U4J2 Bypass Spinal Canal to Atrium with Synthetic Substitute, Percutaneous Endoscopic Approach
001U4J4 Bypass Spinal Canal to Pleural Cavity with Synthetic Substitute, Percutaneous Endoscopic Approach
001U4J6 Bypass Spinal Canal to Peritoneal Cavity with Synthetic Substitute, Percutaneous Endoscopic Approach
001U4J7 Bypass Spinal Canal to Urinary Tract with Synthetic Substitute, Percutaneous Endoscopic Approach
001U4J9 Bypass Spinal Canal to Fallopian Tube with Synthetic Substitute, Percutaneous Endoscopic Approach
001U4K2 Bypass Spinal Canal to Atrium with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
001U4K4 Bypass Spinal Canal to Pleural Cavity with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
001U4K6 Bypass Spinal Canal to Peritoneal Cavity with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
001U4K7 Bypass Spinal Canal to Urinary Tract with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
001U4K9 Bypass Spinal Canal to Fallopian Tube with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00500ZZ Destruction of Brain, Open Approach
00503ZZ Destruction of Brain, Percutaneous Approach
00504ZZ Destruction of Brain, Percutaneous Endoscopic Approach
00510ZZ Destruction of Cerebral Meninges, Open Approach
00513ZZ Destruction of Cerebral Meninges, Percutaneous Approach
00514ZZ Destruction of Cerebral Meninges, Percutaneous Endoscopic Approach
00520ZZ Destruction of Dura Mater, Open Approach
00523ZZ Destruction of Dura Mater, Percutaneous Approach
00524ZZ Destruction of Dura Mater, Percutaneous Endoscopic Approach
00570ZZ Destruction of Cerebral Hemisphere, Open Approach
00573ZZ Destruction of Cerebral Hemisphere, Percutaneous Approach
00574ZZ Destruction of Cerebral Hemisphere, Percutaneous Endoscopic Approach
00580ZZ Destruction of Basal Ganglia, Open Approach
00583ZZ Destruction of Basal Ganglia, Percutaneous Approach
00584ZZ Destruction of Basal Ganglia, Percutaneous Endoscopic Approach
00590ZZ Destruction of Thalamus, Open Approach
00593ZZ Destruction of Thalamus, Percutaneous Approach
00594ZZ Destruction of Thalamus, Percutaneous Endoscopic Approach
005A0ZZ Destruction of Hypothalamus, Open Approach
005A3ZZ Destruction of Hypothalamus, Percutaneous Approach
005A4ZZ Destruction of Hypothalamus, Percutaneous Endoscopic Approach
005B0ZZ Destruction of Pons, Open Approach
005B3ZZ Destruction of Pons, Percutaneous Approach